WeVote
Log In

Bill

Bill

S 4651

Establishes an economy-wide cap and invest program to support greenhouse gas emissions reductions in the state by setting a maximum allowable amount of emissions and regulating the sale or auction of allowances

2025 Regular Session Introduced by Leroy Comrie and 5 co-sponsors

NJ Medicaid would cover continuous glucose monitors for diabetes patients, plus education and medical nutrition therapy, under physician or clinician referral.

PRINT NUMBER 4651A
0
WeVote Research Nonpartisan
Bill Summary · S 4651

Summary — S-4651 (Print No. 4651A) — Medicaid coverage for continuous glucose monitors

Overview / Purpose

S-4651 (Print No. 4651A) amends New Jersey’s Medicaid statute (P.L.1968, c.413; C.30:4D-6) to expand Medicaid-covered diabetes-related services and to require coverage of continuous glucose monitors (CGMs) for eligible Medicaid beneficiaries. The bill integrates CGMs and related diabetes self-management supports into the list of authorized services subject to federal Medicaid requirements and state rules.

Note: metadata supplied with the request contains a different bill title (an economy-wide cap-and-invest program). The text provided and the bill language clearly concern Medicaid coverage for CGMs and diabetes services. This summary follows the legislative text provided.

Key provisions and changes

  • Amends Section 6 of P.L.1968, c.413 (C.30:4D-6) — the statute enumerating services the Department shall or may provide under the State Medicaid program.
  • Adds and clarifies authorized diabetes-related services under the medical assistance program, including:
    • Coverage of diabetes self-management education and training when referred by an authorized clinician and provided by qualified personnel or accredited programs (e.g., Certified Diabetes Educators or ADA-recognized programs).
    • Coverage of medical nutrition therapy for beneficiaries with diabetes, gestational diabetes, or pre-diabetes when clinically appropriate or upon change in condition or treatment.
    • Coverage of continuous glucose monitors (CGMs) for Medicaid beneficiaries with diabetes, pursuant to referral by a physician, advanced practice nurse, or physician assistant and in accordance with American Diabetes Association standards (text indicates CGMs are included though the provided excerpt is truncated).
  • All coverage expansions are subject to Title XIX (federal Medicaid) requirements and any limitations established by federal law, the state statute, and regulations promulgated by the Department.

Who would be affected

  • Directly affected: New Jersey Medicaid (medical assistance) beneficiaries diagnosed with diabetes, gestational diabetes, or pre-diabetes who meet the criteria and clinician referral requirements for diabetes education, medical nutrition therapy, and CGMs.
  • Indirectly affected: Health care providers (physicians, advanced practice nurses, physician assistants, dietitians, certified diabetes educators), managed care organizations that serve Medicaid beneficiaries, and the Division/Department administering Medicaid (implementation, enrollment, prior authorization/coverage policies).
  • Fiscal impact: Expanded coverage would increase Medicaid service utilization and program costs for the State; some costs may be eligible for federal matching funds under Title XIX. The bill text does not include explicit appropriation or an actuarial estimate.

Implementation and timeline / procedural status

  • Introduced: June 23, 2025.
  • Statutory citation amended: P.L.1968, c.413 (C.30:4D-6).
  • Current status (from provided actions): Print Number 4651A; referred to Senate Health, Human Services and Senior Citizens Committee on introduction. (Other recorded actions in February 2025 reference Environmental Conservation committee and printings; those entries appear inconsistent with the June 2025 introduction.)
  • If enacted, the Department of Human Services would need to implement Medicaid coverage policies, eligibility/referral criteria, possible prior authorization rules, and provider payment arrangements consistent with federal Medicaid rules.

Sponsors and related legislation

  • Sponsors: Kevin S. Parker (primary), Joseph F. Vitale (primary), with cosponsors Robert Jackson, Julia Salazar, Patricia Fahy, Leroy Comrie, Kristen Gonzalez.
  • Related/companion bills: Assembly companion A-3975; prior-session related bill S-9228.

Considerations

  • The expansion targets improved diabetes management (education, nutrition therapy, CGMs), which clinical evidence links to better glycemic control and reduced complications.
  • Budgetary implications for State Medicaid and potential offsets (improved health outcomes, reduced acute care) should be analyzed by fiscal staff.
  • Because coverage is tied to federal Medicaid rules, actual implementation, federal approval (where required), and federal matching availability will affect the timing and scope of benefits.

If you want, I can: (1) extract the exact CGM language from the full bill text (if provided), (2) draft a short fiscal impact checklist for state budget staff, or (3) compare this bill’s CGM eligibility criteria to existing NJ Medicaid policy.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.